Sexual dimorphism in lipidomic changes in maternal blood and placenta associated with obesity and gestational diabetes: A discovery study
Placenta · 2025
DOI: 10.1016/j.placenta.2024.12.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2025. Verfasst von Leena Kadam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, USA. Electronic address: kadam@ohsu.edu. Hauptthemen laut MEDLINE: Placenta, Diabetes, Gestational, Obesity, Sex Characteristics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Department of Energy, National Institute of Child Health and Human Development.
Themen: Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION: The placenta uses lipids and other nutrients to support its own metabolism hence impacting the type and amount of these substrates available to the growing fetus. Maternal obesity and gestational diabetes (GDM) can disrupt placental lipid metabolism and thus lead to altered fetal growth contributing to adverse pregnancy outcomes and developmentally programing the offspring for disease in later life. Understanding obesity and GDM driven changes in placental lipid metabolism is thus important. METHODS: We collected maternal plasma and placental villous tissue following elective cesarean section at term from women who were lean (pre-pregnancy BMI 18.5-24.9), obese (BMI>30) or obese with type A2 GDM n = 8 each group (4 male and 4 female placentas). Fatty acid composition of different lipid classes was analyzed by LC-MS/MS analysis. Significant changes in GDM vs obese, GDM vs lean, and obese vs lean were determined in both a fetal sex-dependent and independent manner. RESULTS: In placenta 436 lipids were identified, among which 85 showed significant changes. We report significant changes in placental triglyceride, phosphatidylcholine, and phosphatidylinositol lipids containing essential fatty acids- DHA and AA in GDM, with male placentas driving these changes. In maternal plasma, 284 lipids were identified with 14 showing significant changes, but we observed no changes based on fetal sex. DISCUSSION: Maternal obesity and GDM impact placental lipid composition in a sexually dimorphic manner. The alteration in specific lipid classes can impact cellular energetics and placental function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, USA. Electronic address: kadam@ohsu.edu.
- Pacific Northwest National Laboratory, Richland, WA, USA.
- Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, USA.
Förderung
- NICHD NIH HHS
- Department of Energy
- National Institute of Child Health and Human Development
Zitieren
APA
Kadam, L., Veličković, M., Stratton, K., Nicora, C. D., Kyle, J. E., Wang, E., Monroe, M. E., Bramer, L. M., Myatt, L., & Burnum-Johnson, K. E. (2025). Sexual dimorphism in lipidomic changes in maternal blood and placenta associated with obesity and gestational diabetes: A discovery study. Placenta. https://doi.org/10.1016/j.placenta.2024.12.002
Vancouver
Kadam L, Veličković M, Stratton K, Nicora CD, Kyle JE, Wang E, et al. Sexual dimorphism in lipidomic changes in maternal blood and placenta associated with obesity and gestational diabetes: A discovery study. Placenta. 2025. doi:10.1016/j.placenta.2024.12.002
BibTeX
@article{Kadam2025,
author = {Kadam, Leena and Veličković, Marija and Stratton, Kelly and Nicora, Carrie D and Kyle, Jennifer E and Wang, Eric and Monroe, Matthew E and Bramer, Lisa M and Myatt, Leslie and Burnum-Johnson, Kristin E},
title = {Sexual dimorphism in lipidomic changes in maternal blood and placenta associated with obesity and gestational diabetes: A discovery study},
journal = {Placenta},
year = {2025},
doi = {10.1016/j.placenta.2024.12.002}
}
EUVIMED